The Cooper Companies (COO) Q4 earnings: Taking a look at key metrics versus estimates
|For the quarter ended October 2025, The Cooper Companies (COO) reported revenue of $1.07 billion, up 4.6% over the same period last year. EPS came in at $1.15, compared to $1.04 in the year-ago quarter.
The reported revenue compares to the Zacks Consensus Estimate of $1.06 billion, representing a surprise of +0.45%. The company delivered an EPS surprise of +3.6%, with the consensus EPS estimate being $1.11.
While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their next move, some key metrics always offer a more accurate picture of a company's financial health.
Since these metrics play a crucial role in driving the top- and bottom-line numbers, comparing them with the year-ago numbers and what analysts estimated about them helps investors better project a stock's price performance.
Here is how The Cooper Companies performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:
- Revenue by geography- Americas: $285.1 million versus $291.49 million estimated by two analysts on average. Compared to the year-ago quarter, this number represents a +5.4% change.
- Revenue by geography- Asia Pacific: $147.4 million versus the two-analyst average estimate of $139.8 million. The reported number represents a year-over-year change of -1.3%.
- Revenue by geography- EMEA: $277.1 million versus the two-analyst average estimate of $269.49 million. The reported number represents a year-over-year change of +8%.
- Revenue by category- CVI: $709.6 million compared to the $707.83 million average estimate based on five analysts. The reported number represents a change of +4.9% year over year.
- Revenue by category- CSI: $355 million versus $352.65 million estimated by five analysts on average. Compared to the year-ago quarter, this number represents a +3.8% change.
- Revenue by category- CSI- Office and surgical: $214.6 million versus $208.89 million estimated by four analysts on average. Compared to the year-ago quarter, this number represents a +5.8% change.
- Revenue by category- CSI- Fertility: $141 million compared to the $144.03 million average estimate based on four analysts. The reported number represents a change of +1.3% year over year.
- Revenue by category- CVI- Sphere, other: $365 million compared to the $362.34 million average estimate based on four analysts. The reported number represents a change of +3.3% year over year.
- Revenue by category- CVI- Toric and multifocal: $344.6 million versus $346.45 million estimated by four analysts on average. Compared to the year-ago quarter, this number represents a +6.6% change.
Information on these pages contains forward-looking statements that involve risks and uncertainties. Markets and instruments profiled on this page are for informational purposes only and should not in any way come across as a recommendation to buy or sell in these assets. You should do your own thorough research before making any investment decisions. FXStreet does not in any way guarantee that this information is free from mistakes, errors, or material misstatements. It also does not guarantee that this information is of a timely nature. Investing in Open Markets involves a great deal of risk, including the loss of all or a portion of your investment, as well as emotional distress. All risks, losses and costs associated with investing, including total loss of principal, are your responsibility. The views and opinions expressed in this article are those of the authors and do not necessarily reflect the official policy or position of FXStreet nor its advertisers.